Crawford Investment Counsel Inc. decreased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 3.4% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 321,302 shares of the technology company’s stock after selling 11,440 shares during the period. Crawford Investment Counsel Inc. owned 1.85% of Simulations Plus worth $6,490,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of SLP. Wasatch Advisors Inc. acquired a new position in shares of Simulations Plus during the 3rd quarter valued at about $5,385,000. BlackRock Inc. increased its holdings in shares of Simulations Plus by 12.4% during the 2nd quarter. BlackRock Inc. now owns 846,454 shares of the technology company’s stock valued at $18,833,000 after acquiring an additional 93,438 shares during the last quarter. Millennium Management LLC acquired a new position in shares of Simulations Plus during the 1st quarter valued at about $752,000. Renaissance Technologies LLC increased its holdings in shares of Simulations Plus by 6.4% during the 2nd quarter. Renaissance Technologies LLC now owns 592,100 shares of the technology company’s stock valued at $13,174,000 after acquiring an additional 35,600 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Simulations Plus by 6.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 506,064 shares of the technology company’s stock valued at $11,260,000 after acquiring an additional 30,848 shares during the last quarter. 38.26% of the stock is currently owned by institutional investors and hedge funds.
SLP has been the topic of a number of research analyst reports. BidaskClub raised Simulations Plus from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 27th. Zacks Investment Research lowered Simulations Plus from a “buy” rating to a “hold” rating in a report on Wednesday, September 19th.
Simulations Plus (NASDAQ:SLP) last released its earnings results on Wednesday, November 14th. The technology company reported $0.07 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.01. The firm had revenue of $6.70 million for the quarter, compared to analyst estimates of $5.98 million. Simulations Plus had a return on equity of 24.97% and a net margin of 30.11%. Equities research analysts forecast that Simulations Plus, Inc. will post 0.52 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, November 8th. Shareholders of record on Thursday, November 1st were issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 1.24%. The ex-dividend date was Wednesday, October 31st. Simulations Plus’s dividend payout ratio (DPR) is currently 48.00%.
In other Simulations Plus news, Director Walter S. Woltosz sold 18,500 shares of the firm’s stock in a transaction that occurred on Monday, October 29th. The stock was sold at an average price of $20.01, for a total value of $370,185.00. Following the sale, the director now owns 5,399,408 shares of the company’s stock, valued at approximately $108,042,154.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 55,500 shares of company stock worth $1,114,810 in the last ninety days. Insiders own 33.45% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This piece of content was reported by WKRB News and is the property of of WKRB News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.wkrb13.com/2018/11/24/crawford-investment-counsel-inc-has-6-49-million-stake-in-simulations-plus-inc-slp.html.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Read More: How Buying a Call Option Works
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.